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Abstract: Primary cilia are microtubule-based organelles found in most mammalian cell types.
Cilia act as sensory organelles that transmit extracellular clues into intracellular signals for molecular
and cellular responses. Biochemical and molecular defects in primary cilia are associated with a
wide range of diseases, termed ciliopathies, with phenotypes ranging from polycystic kidney disease,
liver disorders, mental retardation, and obesity to cardiovascular diseases. Primary cilia in vascular
endothelia protrude into the lumen of blood vessels and function as molecular switches for calcium
(Ca2+) and nitric oxide (NO) signaling. As mechanosensory organelles, endothelial cilia are involved
in blood flow sensing. Dysfunction in endothelial cilia contributes to aberrant fluid-sensing and thus
results in vascular disorders, including hypertension, aneurysm, and atherosclerosis. This review
focuses on the most recent findings on the roles of endothelial primary cilia within vascular biology
and alludes to the possibility of primary cilium as a therapeutic target for cardiovascular disorders.
Keywords: primary cilia; calcium; nitric oxide; biochemical signaling; hypertension; aneurysm;
atherosclerosis
1. Introduction
Cilia have been studied for their motile functions of lung epithelium, sperm cells, as well as in
other organisms (such as algae) [1]. These motile cilia, in most cases, have 9 + 2 microtubule structural
arrangement. Researchers have also gained interest in studying non-motile cilia [2]. Non-motile cilia
also known as primary cilia have a 9 + 0 microtubule structural arrangement. Defects in primary cilia
could cause various life-threatening diseases in humans, such as neural tube defects, which result in
numerous abnormalities of the brain and spinal cord in patients diagnosed with Meckel syndrome,
for example [3]. Several studies have shown that primary cilia are recognized as mechanical and
chemical sensory organelles which serve as antennae to transmit extracellular to intracellular signaling
mechanisms. Because primary cilia act as sensory organelles by which cells sense and transduce
extracellular signals [4], any defects in primary cilia function could potentially cause several diseases
which are collectively known as ‘ciliopathies’ (Table 1). The list of human ciliopathies has increased
in recent years [5,6]. Mutations in approximately 50 genes have revealed to alter ciliary assembly or
function, and as many as 1000 different ciliary proteins are still with undetermined functions and
required further investigation. Hence, abnormal ciliary proteins can be associated with a single organ
dysfunction to systemic multiple organ complications depending on the type of cells affected [7].
Cilia dysfunction has been implicated in polycystic kidney disease (PKD), obesity,
nephronophthisis, mental retardation, Bardet-Biedl syndrome, oral facial syndrome, vascular diseases
and others [7]. Specifically, impaired primary cilia on endothelial cells have important clinical
consequences and are associated with many vascular diseases [8,9]. Although it has been over a
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century since primary cilia have been visualized, the study of their mechano- and chemo-sensory
roles remains relatively a new field of study. Additionally, studies on endothelial primary cilia
function of the vascular system and primary cilia as a therapeutic target for vascular diseases are still
limited. In this review, the roles of primary cilia will be discussed with emphasis on the cardiovascular
diseases [10–13]. Hence, it is important to have a clear understanding about ciliary structure and
functional ciliary proteins to investigate how cilia dysfunction can contribute to vascular disorders of
hypertension, aneurysm and atherosclerosis.
Table 1. Ciliary function and disease relevance.
Function Disease Relevance Reference
Nodal flow sensing Situs inversus; Situs ambiguous; Situs isomerism [14,15]
Mechano-sensing Kidney, Liver, and Pancreas Diseases [16–18]
Shear stress sensing Hypertension; Atherosclerosis; Aneurysm formation [10–13]
Osmolarity sensing Respiratory diseases; Infertility [19,20]
Gravitational sensing Osteoporosis; Chondroporosis [21–23]
Olfaction sensing Anosmia; Hyposmia [24,25]
Light sensing Retinitis pigmentosa; Blindness [26–28]
Chemo-sensing Nephrocystin; Diabetes; Obesity [29–31]
Neurotransmitter sensing Impaired brain plasticity [32]
Developmental regulatory sensing Developmental defects; Cancer [33–35]
Pressure sensing Bone maintenance, development [22,36,37]
2. Cilia Structure
A cilium is considered as a cellular organelle, which is primarily composed of a membrane, soluble
compartment, axoneme, basal body, and ciliary tip [38]. A cilium extends from a basal body complex,
which is mainly composed of two centrioles. One of the centrioles is known as the mother centriole,
to which the ciliary axoneme is ingrained beneath the cell membrane. The cilium structure contains
the microtubular portions of cytoskeletal core unit called the axoneme (Figure 1). The axonemal
structure contains nine peripheral doublet microtubules, which are made of alpha- and beta-tubulins
and are post-translationally acetylated to support the long cilia structure [39–41]. The non-motile
axoneme structure lacks the central pair of microtubules (9 + 0) [42,43]. In the blastocyst nodal cilia,
the axoneme lacks the central pair of microtubules (9 + 0) but shows motility. This exception requires
both dynein arms for motility [44]. Of note is that the lack of radial spokes induces rotational motion
instead of beating motion, suggesting that the absence of radial spokes allows nodal cilia to rotate
unidirectionally but, as a trade-off, renders them ultrastructurally fragile [44]. While in most cases
of motile cilia, the axoneme contains nine peripheral doublet microtubules and a central pair of
microtubules (9 + 2) [45]. There is a connection between the microtubular portion of the cytoskeleton
and the ciliary axoneme, and the disruption of cytoplasmic microtubules or actin filaments, which could
affect microtubules assembly resulting in the loss of ciliary structural integrity and mechanosensory
function [46–48]. On the other hand, protein entering and exiting through cilium is controlled by
a proteomic barrier at the ciliary base that encompasses a transition zone which separates cytosol
from the cilia [49–52]. The ciliary membrane is connected with the plasma membrane but possesses a
lipid bilayer composition that differs from the plasma membrane compositions [53]. The periciliary
membrane, also known as the transition-membrane, connects ciliary and plasma membrane to form
the ciliary pocket [54,55]. In addition to its fundamental structural role, the basal body connected to
the transition-membrane is thought to regulate protein entry and exit from the ciliary compartment.
Furthermore, the mechanoreceptors, protein transporters, sensory proteins and ligand-gated ion
channels are involved in signal transduction enclosed within the ciliary membrane. The axoneme
allows the intraflagellar signaling and intraflagellar transport (IFT) activities along with ciliary shaft
using the soluble compartment, also called cilioplasm. Primary cilium lacking ribosomes is incapable
of producing its own proteins required for the elongation and continuous turnover of axoneme
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necessary for self-safeguarding. Moreover, each part of this cilia structure is crucial to support various
signaling molecules. Some of the more established cilia-dependent signaling pathways are already
described [38].
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3. Primary Cilia as a Blood Flow Sensor
Flow sensing by the cilia permit cells to sense blood flow along the blood vessels, urine
flow through kidneys, bile acid in the liver, pancreatic secretions in the duodenum, nodal flow
in Hansen’s node (the site which determines the patterns the anterior-posterior axis of the
embryo during gastrulation), interstitial fluid flow within the bone canaliculi, and potentially
other systems/organs [56]. The function of the vascular system depends on the mechanical fluid
flow signaling from the blood flow. Several studies have also reported that the presence of
primary cilia in major circulatory systems including endocardia [13,57], arteries [58,59], veins [60],
corneal endothelium [61,62], and smooth muscle cells of both arterial and airway endothelia [63,64].
The continuous contraction and relaxation of smooth muscle cells produce changes in the blood vessels
diameter, which is important for normal blood flow [65–67]. Increase in vascular stiffness is a major
cause of hypertension, which leads to complications including ventricular hypertrophy, vascular
aneurysm and atherosclerosis [68–72]. These changes suggest that smooth muscle cells or neuronal
regulations are important in regulating the vascular tone in addition to the mechanical fluid-flow
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within the blood vessel. The regulation of circulatory function is acquired by neuronal regulators
through central and/or peripheral neurons [73–75].
The mechanical fluid-flow provides local regulation or autoregulation within a blood vessel.
For example, autoregulation is required to achieve immediate blood flow control in specified area
of the tissue. Autoregulation is independent of the neighboring tissues and has little to no effect
on the surrounding tissues [76,77]. In an isolated blood vessel, the sudden increase of transmural
blood pressure causes a reduced vessel diameter [78–80], whereas high flow stress increases vessel
diameter [67,80–82]. As such, the lining of the inner surface of vascular blood vessels are endothelial
cells with primary cilia protrusions, which can sense changes in blood velocity and pressure and
convert these mechanical signals into changes of vascular smooth muscle tone [83,84]. In a biophysical
perspective, fluid-shear stress refers to the partial or frictional force of blood flow as it brushes against
the vascular endothelia [85]. This frictional force is not stable because blood flow changes with each
heart muscle contraction, resulting in pulsatile patterns of blood flow [85]. As a result, blood flow
through a vessel creates different types of forces such as stretch, compression, cyclic strain, pressure
and shear stress. While these forces may be practically impossible to differentiate in vivo, they can be
independently studied in in vitro and ex vivo studies [86].
Our earlier studies show that the primary endothelial cilia act as a mechanosensor in in vitro
(mouse aortic endothelial cells), ex vivo (isolated mouse arteries, blood vessels from human patients)
and in vivo (mouse models) [11,12,58]. Ciliary length is also positively correlated with mechanosensory
action. Blood vessels with relatively a low fluid force have longer cilia while blood vessels with a high
fluid force are devoid of cilia or have very short cilia. In addition, the changes in fluid dynamics affect
endothelial cilia distribution and depend on fluid-flow intensity with longer cilia present in lower
fluid-flow areas [13,87]. This is because of the inability of primary cilia to stand against high levels of
fluid flow, which results in ciliary disassembly and loss of intraflagellar transport which is necessary
for ciliary reassembly [88]. Subsequently, the mechanosensing function of cilia in high fluid flow areas
could be replaced by other mechanisms like glycocalyx to sense higher shear forces [89].
Primary cilia have a critical role in sensing the extracellular stimuli, such as odorant or chemical
(chemosensory) and movement (mechanosensory). These stimulations are then translated into
intracellular signals. As a mechanosensor, a primary cilium can sense the fluid-flow in multiple
cell types including renal epithelial and vascular endothelial cells [12,18,90]. Polycystin-1 (PC1) and
polycystin-2 (PC2) form a mechanosensory complex in the primary cilia. It is recently shown that
the PC1 and PC2 form a complex and are assembled in a stoichiometry of 3 PC2 for every PC1
molecule [91]. The PC1 and PC2 complex detects the bending of the cilia by the fluid flow leading to an
increase in Ca2+ influx and an inhibition of the regulated intramembrane proteolysis (RIP) of PC1 by
keeping the signal transducer and activator of transcription (STAT) factor 6 and its coactivator P100 in
a complex bound to PC1 tail [92,93]. This is how primary cilia is thought to promote proliferation and
differentiation through fluid-shear stress. On the other hand, the absence or lack of flow as well as loss
or dysfunction of cilia, PC1, or PC2 decrease Ca2+ influx and activate RIP that allows STAT6 and P100
to translocate to the nucleus and stimulate transcription resulting in uncontrolled cell proliferation
and cyst formation [94,95]. In particular, PC1 and PC2 are widely expressed across the vasculature,
and they are hypothesized to play a major role in the development, maintenance, and function of the
myoelastic arteries [96–98]. These observations indicate a direct pathogenic role for both PC1 and PC2
in the vascular complications of hypertension, aneurysm and/or atherosclerosis.
4. Role of Primary Cilia in Heart Development
Nodal cilia probably have the earliest cilia function during embryonic development. During
gastrulation period, both motile (nodal) and non-motile cilia at the embryonic node play an important
role in regulating signaling cascades required for the formation of left-right asymmetry, a process which
regulates the early stages of cardiogenesis and connection to the blood vessels [15,99–102]. Fluid flow
plays an important role in trabeculation, cardiac cell proliferation, and formation of conduction system,
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in addition to changes in fluid-shear forces, which lead to cardiac diseases. Cilia in cardiomyocytes
have a series of receptors, which take part in regulating cellular signaling mechanisms required for
the continuous differentiation, morphogenesis and development of the heart [103–106]. Independent
studies have established the important role of heart cilia in cardiac development. Defects in cilia
structure or function lead to severe inherited cardiac diseases. Also, defects in cilia result in a variety
of heart developmental defects such as arterial and ventricular septum defects [107,108], abnormal
looping, and remodeling of the heart tube into a multi-chambered organ [109–114] or myocardial
wall disorganization [115]. Moreover, mice with a mutation in cilia structural gene ift88, kif3a or
kif3b are characterized by severe heart phenotypes including hypoplasia of the endocardial cushions,
a reduction in ventricular trabeculation, and an increase in volume of pericardial space including
defective cardiac looping [102]. A variety of signaling pathways are involved directly or indirectly in
heart development. For example, Hedgehog (Hh) signaling coordinated by primary cilia in a variety
of cells controls tissue patterning and promotes the activation of different transcriptional factors
involved in different cellular signaling mechanisms during homeostasis in vertebrates [116,117]. As a
result, defects in primary cilia Hh signaling leads to severe cardiac disorders including congenital
heart diseases [118]. Another example of a signaling pathway which plays an important role in
cardiac morphogenesis is the superfamily of Transforming Growth Factorβ/Bone Morphogenic Protein
(TGFβ/BMP). TGFβ/BMP signaling network is involved in a wide range of cellular mechanisms and
processes and is therefore fundamentally vital during tissue homeostasis and morphogenesis [119].
Recent studies show that primary cilia can regulate the canonical TGFβ signaling network through the
activation of transcription factors Smad2/3 at the ciliary pocket [104]. Furthermore, the TGFβ ligand,
TGF-β1, stimulates the differentiation of stem cells into cardiomyocytes and that Ift88/Tg737 (Tg737orpk)
mouse embryonic fibroblasts are characterized by decreased TGFβ activity associated with reduced
clathrin-dependent endocytosis activity at the ciliary base, suggesting that cardiac primary cilia play a
direct role in regulating TGFβ signaling during cardiomyogenesis. Recent findings further show that
platelet-derived growth factor receptor-α (PDGFRα) localizes to primary cilia in mutant mouse heart,
indicating that a portion of the PDGF signaling pathway is associated with cardiac primary cilia during
cardiac morphogenesis and development [105]. The localization of PDGFRα causes downregulation
of Hh signaling in primary cilia and causes diminished ventricular wall thickness and ventricular
septal defect [105]. Further, mice studies show that mutated or the absence of PDGFRα, consequences
arise in prenatal mortality such as heart defects including weakened myocardium, thinned septa and
valve, outflow tract, and aortic branch malformations [120–122]. Taken together, the PDGF signaling
system might be specifically coordinated by cardiac primary cilia, potentially acting as signaling hubs
facilitating the cross-talk between different signaling networks in order to coordinate cardiogenesis.
5. Role of Primary Cilia in Biochemical Signaling and Hypertension
As mechanosensory organelles, primary cilia depend on various receptors expressed on the ciliary
membrane. Vascular endothelial cells lining the blood vessel wall are in continuous contact with
blood flow forces. Activation of primary cilia by blood flow leads to the activation of PC1 and PC2
resulting in an intracellular Ca2+ signaling network involving calmodulin (CaM), calcium-dependent
protein kinase (PKC), serine-threonine kinase/protein kinase B (Akt/PKB) and endothelial nitric
oxide synthase (eNOS). Such biochemical reaction generates nitric oxide (NO) leading to vasodilation
(Figure 2). There are two major proposed mechanisms for primary cilia detection of blood flow
forces [85]. The first suggests that ciliary bending occurs upon exposure to blood flow-pressure force,
which triggers cytoskeletal distortion. The second suggests that cilia bending triggers activation of PC1
mechanosensory protein and PC2 cation Ca2+ channels. It is proposed that the increase in intracellular
Ca2+ is caused by an increase in intraciliary Ca2+ [123], whereas another study has suggested that
Ca2+ could be rallied in both directions between the cilia and the cytoplasm [124]. While differences in
the intraciliary Ca2+ can be due to the sensitivity of the cilia-specific Ca2+ probes [125], both studies
show a consensus that mechanosensing function of cilium involves cytosolic Ca2+ signaling as shown
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independently by other laboratories [17,126,127]. Thus, it is fair to assess that primary cilia are
Ca2+-responsive mechanosensors that can trigger a diverse biochemical signaling.ells 2018, 7, x FOR PEER REVIEW  6 of 18 
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influx. This generates a cascade of various protein activation and ultimately leads to endothelial
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calcium-dependent protein kinase (PKC) and serine-threonine kinase/protein kinase B (Akt/PKB) are
involved in maintaining a healthy vascular structure. Abnormality in primary cilia has been proposed
to promote vascular atherosclerotic formation.
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the biochemical reaction in producing NO. Though eNOS triggering is principally a Ca2+-dependent
process, some studies have suggested a Ca2+-independent pathway in NO biosynthesis is also possible.
This Ca2+-independent pathway depends on the heat shock protein 90 (HSP90) [129,130]. HSP90 is
a molecular chaperone, but it may also act as a signal transduction agent concomitant with eNOS
in several systems, including the cardiovascular system. HSP90 also localizes to primary cilia [131].
Although its activation can increase eNOS action in presence of Ca2+-CaM [129,132,133], it is unclear if
cytosolic HSP90 is involved in this signaling pathway.
Dopamine signaling is considered to be an important signaling mechanism in the nervous,
immune, cardiovascular, and renal systems [134]. Dopamine is an endogenous catecholamine hormone
that is mainly produced in the brain and adrenal gland and is also biosynthesized in renal proximal
tubules [135–137]. Dopamine, an endogenous hormone in the sympathetic nervous system, is known
to be intricated in the regulation of hypertension. For example, abnormalities in dopamine signaling
can contribute to high blood pressure in humans. The five G-protein-couple dopamine receptors (DR)
are categorized into D1-like (DR1 and DR5) and D2-like (DR2, DR3, and DR4) families. Several in vitro
and in vivo experiments confirm the presence of Dopamine 1-like receptors, DR1 and DR5, on primary
cilia [59,138–141]. Studies have identified DR5 receptors in cultured mouse vascular endothelial cilia
and mouse arteries in vivo. The DR modulates cilia mechanosensory function by altering fluid flow
sensitivity. Rat studies also show that dis-integrin and metalloproteinase with thrombospondin motifs
16 (Adamts16) play a crucial role in blood pressure control. Further, interruption of the Adamts16 gene
results in longer vascular endothelial primary cilia and significantly lower systolic blood pressure [58].
To date, there are no drugs available that specifically target DR in the cilia, but studies using agents
selective for DR1-like receptor subtypes have shown vasodilatory outcomes in peripheral arteries.
Activation of DR5 using dopamine increases ciliary length while inhibition of DR5 leads to the loss
of ciliary sensory (chemo and mechano) activity [59]. These results are confirmed by challenging
endothelial ciliary knockout cells, Pkd1−/− and no or short cilia Tg737orpk/orpk with dopamine under
static conditions, resulted in a considerably less Ca2+ influx than wild-type endothelial cells. As Ca2+
fluxes in these cells are often concomitant with activation of eNOS, the results may indicate a potential
reestablishment of the missing vasodilatory reactions caused by a failed ciliary generation of NO
biosynthesis. Likewise, there are DR within blood vessels in human, and activation of DR triggers a
vasodilatory action [142].
Cilia dysfunction causes abnormal Ca2+ signaling and kidney disorders such as autosomal
dominant polycystic kidney disease (ADPKD), which is a genetic disease caused by a mutation in
ciliary PC1 or PC2 [6]. Cardiovascular malformations including high blood pressure and left ventricular
hypertrophy notably contribute to mortality in ADPKD patients. A recent clinical review involving
1877 ADPKD patients shows that the use of antihypertensive medications in ADPKD patients have
been increased from 32% in 1991 to 62% in 2008 [143]. This has important clinical consequences as
another study has found that border-line hypertension in ADPKD patients show a better response
with a dopamine precursor relatively to the angiotensin-converting enzyme inhibitor [144]. When
individuals are perfused with 0.25–0.5 µg/kg/min of dopamine, the results indicated an upward
trend in flow-mediated dilation in ADPKD patients and reported a statistically significant decrease in
hypertension [145]. It is currently studied to better understand if the dopamine-induced vasodilation
is a cilia-dependent process [146]. A more recent study, however, seems to support the idea of cilia
involvement in hypertension [147]. The study shows that cilia function is impaired in endothelial cells
from patients with pulmonary arterial hypertension due to the inflammation, and cilia length plays
an important role in response to inflammatory signaling, such as pro-inflammatory cytokines and/or
anti-inflammatory interleukins. The results show that the pro-inflammatory cytokines help in increase
cilia length and is PKA/PKC-dependent, whereas anti-inflammatory interleukins induce a reverse
effect on cilia length. It is therefore postulated that the length of endothelial cilia is associated with
endothelial function and pulmonary arterial pressure.
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6. Role of Primary Cilia in Vascular Aneurysm
An aneurysm is a formation of an abnormal swelling in a weak area of a blood vessel that can
rupture, leading to bleeding and possibly to death. The most common arteries that can be affected
by aneurysm are cerebral arteries and aortic artery. Aneurysm formation and rupture are considered
one of the major complications associated with ADPKD, in which PC1 is required for structural
integrity of blood vessel [148]. Thus, PC1 and PC2 functions are required in blood vessels [97,98,149],
and, any abnormalities in either protein leads to aneurysm formation [150]. Of note: In ADPKD
patients, the aneurysm can occur in different arteries such as the aorta, splenic, coronary, and cerebral
arteries [151–154].
Within the arteries, primary cilia play an important role in the structure and the function of
endothelial cells [12,60]. Therefore, the absence or dysfunction of primary cilia can induce aneurysm
formation and progression during vascular injuries [10,155]. Vascular aneurysms are associated with
tissue remodeling due to unusual proliferation of the endothelial cell layers through the hemodynamic
fluctuations in fluid-shear forces [156]. Endothelial cilia are required for shear stress-induced Ca2+
influx and NO signaling [11], and eNOS deficiency is the hallmark of endothelial dysfunction and
associated with cardiovascular complications including aneurysm, indicating the protective role of
eNOS [157]. Primary cilia regulate endothelial actin organization and focal adhesion assembly that can
affect directional migration and cell permeability through hsp27 and Notch/foxc1b signaling [158,159].
It is therefore thought that the mechano-sensation of primary cilia is essential in promoting proper
vascular development.
Previously, we showed that the similarity of the pathogenesis between cyst formation and
aneurysm associated with PKD in mice models (PdgfβCre:Survivinflox/flox, PdgfβCre:Pkd1flox/flox and
PdgfβCre:Tg737flox/flox). Dysfunction of the primary cilia induces an abnormal survivin expression that
results in irregular cytokinesis leading to cell polyploidy, multi-mitotic spindle formation and aberrant
cell division orientation. This abnormality in symmetrical cell division and cell ploidy leads to the
extension of tissue architecture, developing cysts in the kidney and aneurysm in the vasculature [10].
PKC and Akt are downstream signaling messengers of primary cilia, and they regulate survivin
expression following primary cilia activation. Akt is downstream of PKC and can regulate Nuclear
Factor-κB, which regulates the expression of survivin. All in all, the inability of primary endothelial
cilia to respond to fluid flow can contribute to the vascular aneurysm.
7. Role of Primary Cilia in Atherosclerosis
Atherosclerosis plaques mainly develop in the arterial system with bifurcations, branch points,
or the inner curvature of arched arteries. Atherosclerosis plaques are often observed at sites with
low and oscillating fluid-flow within the embryonic cardiovascular system [13,57]. Plaques happen
most frequently in areas of great curvature and branch points in addition to low fluid forces or
non-unidirectional flow [160,161]. Like cilia which are present only at the regions of inner curvature
of the artery arch [13], atherosclerotic plaques do not happen homogenously along the circulatory
system. A recent report confirms that removing endothelial cilia from the vascular branch points
causes abnormal fluid-flow responses that contribute to the atherosclerosis [162]. Moreover, exposure
of endothelial cells to oscillatory fluid-flow results in the disengagement of eNOS, which promotes
reactive oxygen species (ROS) formation rather than NO, leading to atherosclerosis plaque growth [163].
There is an upregulation of inflammatory gene expression in areas with disturbed blood flow, and this
further promotes plaque formation and hyperlipidemia [164,165].
The role of primary cilia in the development of atherosclerosis has been revealed in the
apolipoprotein-E-deficient mouse model (Apoe−/−) with a high fat and cholesterol diet [162]. Increasing
numbers of the endothelial primary cilia existed in atherogenesis areas under hyperlipidemia-induced
lesion formation. Tek-Cre•Ift88C/−•Apoe−/−, in which endothelial Ift88 was specifically ablated,
displayed a significantly greater increase in plaque formation compared to that established by their
wildtype littermates. The lack of endothelial cilia in vascular branches result in significant upregulation
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lymphocyte markers, macrophage marker genes, along with proinflammatory cytokines [162].
Atherosclerosis lesions increase in the mice who lack endothelial cilia by 59% in females, and 67% in
males as compared to the control mice. This is measured by counting atherosclerotic lesioned surface
area. Furthermore, lacking endothelial cilia enhances inflammatory gene expression and a decrease in
endothelial nitric oxide synthase activity. Hence, it is proposed that vascular endothelial cilia play an
important role in control of atherosclerosis.
8. Role of Primary Cilia in Cell Proliferation
Not only do primary cilia provide a sensory signaling hub, they also play an important role in cell
proliferation. Ciliogenesis begins at the G1/G0 phase of the cell cycle, and resorption or disassembly
of cilia starts after the cell cycle re-entry. Primary cilia formation is influenced by the coordination
of assembly/disassembly equilibrium, IFT system, and membrane trafficking [166]. Specifically,
ciliogenesis involves multiple steps and is correlated with cell division. First, the centrosome travels to
the cell surface and the basal body is formed by the mother centriole to nucleate ciliary axoneme at
the G1/G0 phase of the cell cycle. This step which involves membrane docking is regulated by the
distal appendage proteins, such as centrosomal protein 164 (Cep164). On the other hand, CP110, Ofd1,
and trichoplein are negative regulators of ciliogenesis targeting ciliary extension. Second, elongation
of the cilium and maintenance of ciliary length occur. This process is negatively regulated by Nde1
until mature primary cilium is formed. Third, upon cell cycle entry, ciliary resorption occurs followed
by axoneme shortening. Ciliary disassembly is controlled by Aurora A-HDAC6, Nek2-Kif24, and
Plk1-Kif2A pathways. Fourth, the basal body is released from cilia; thus, centrioles (centrosome)
become free to act as microtubule organizing center (MTOC) or spindle poles during mitosis [166–168].
In tumors, cilia are not present on most proliferative cells suggesting that although cilia are not
directly required during cell proliferation, they do play a key role in the entry and exit of mitosis [169–
171]. PC1 has been shown to mediate JAK/STAT pathway [172]. Ciliary PC1 is able to activate STAT3;
when the cytoplasmic tail of PC1 is cleaved in response to fluid-flow, it can coactivate STAT-1, 3, and 6
as well as JAK2 [92]. The PC1 tail triggers several cytokines and growth factor signaling, amplifying the
cellular response and potentially leading to an increase in L-arginine thus arresting cell proliferation.
Although the reason of the absence of cilia in cancer cells is not exactly known, this phenomenon
is arguably not surprising given that the presence of cilia is a cell-cycle-dependent process [173].
Thus, cilia are not expected to be present in highly proliferative cells. However, what complicates the
discussion is that primary cilia have also been reported in cancers, including in medulloblastoma [34,
174], basal cell [33] and gastroinstestinal stroma cells [175]. A recent study suggests a possibility of an
enzymatic effect in cancer cells [176]. It is shown that posttranslational modification of ciliary tubulin
is affected and resulted in less robust formation of primary cilia. Lacking proper posttranslational
modification in ciliary exoneme may therefore increase a risk factor for cancer development [176].
9. Conclusions and Perspective
Both primary cilia structure and sensory functions are essential for normal tissue homeostasis
and function. The in vitro and ex vivo fluid-flow studies have greatly advanced our knowledge of the
chemo- and mechano-sensory function of primary cilia in cardiovascular systems. More studies are
warranted towards clinical intervention for hypertension, aneurysm and atherosclerosis. Unfortunately,
there are no pharmacological agents available that selectively target primary cilia. While this review
mostly represents a small portion of possible connections between primary cilia and cardiovascular
disorders, we may need a large-scale screening study to include potential pharmacological agents in
order to understand whether or not targeting sensory functions of primary cilia would result in better
cardiovascular outcomes.
Primary cilia are ubiquitously present in many organ systems, including the cardiovascular
system. Emerging data suggest that cilium dysfunction is a primary cause in many cardiac and vascular
disorders. Over the past years, researchers have provided tremendous advances in understanding
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of the basic cellular and molecular functions of primary cilia. Despite the fact that more research
is needed, we should also extend ourselves by integrating the basic science knowledge into clinical
considerations and perspectives. Otherwise, we are not able to see the forest because we are too
focused on the trees.
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